Novo Nordisk (0QIU) Ratios
Novo Nordisk Ratios
GB:0QIU's free cash flow for Q2 2026 was $42.40B. For the 2026 fiscal year, GB:0QIU's free cash flow was decreased by $-12.80B and operating cash flow was $55.20B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.80 | 0.74 | 0.82 | 0.89 | 0.86 |
| Quick Ratio | 0.57 | 0.55 | 0.64 | 0.69 | 0.66 |
| Cash Ratio | 0.12 | 0.07 | 0.08 | 0.10 | 0.11 |
| Solvency Ratio | 0.34 | 0.34 | 0.45 | 0.40 | 0.43 |
| Operating Cash Flow Ratio | 0.55 | 0.56 | 0.64 | 0.65 | 0.55 |
| Short-Term Operating Cash Flow Coverage | 9.91 | 10.27 | 20.53 | 164.35 | 4.28 |
| Net Current Asset Value | $ -176.40B | $ -161.41B | $ -68.28B | $ -49.58B | $ -38.17B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.24 | 0.22 | 0.09 | 0.11 | 0.14 |
| Debt-to-Equity Ratio | 0.67 | 0.72 | 0.25 | 0.31 | 0.38 |
| Debt-to-Capital Ratio | 0.40 | 0.42 | 0.20 | 0.24 | 0.27 |
| Long-Term Debt-to-Capital Ratio | 0.37 | 0.37 | 0.13 | 0.20 | 0.12 |
| Financial Leverage Ratio | 2.80 | 3.25 | 2.95 | 2.89 | 2.75 |
| Debt Service Coverage Ratio | 6.45 | 8.11 | 15.50 | 60.89 | 4.07 |
| Interest Coverage Ratio | 18.83 | 66.53 | 138.80 | 133.83 | 142.69 |
| Debt to Market Cap | 0.09 | 0.03 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 31.00 | 23.51 | 6.19 | 5.81 | 5.89 |
| Net Debt to EBITDA | 0.70 | 0.63 | 0.11 | 0.17 | 0.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 80.98% | 84.67% | 84.60% | 83.92% | 83.20% |
| EBIT Margin | 43.60% | 44.36% | 45.30% | 39.24% | 42.17% |
| EBITDA Margin | 48.34% | 47.31% | 49.35% | 43.40% | 46.44% |
| Operating Profit Margin | 41.30% | 44.19% | 44.16% | 42.28% | 41.65% |
| Pretax Profit Margin | 42.24% | 43.80% | 45.07% | 39.03% | 41.96% |
| Net Profit Margin | 33.14% | 34.78% | 36.03% | 31.38% | 33.92% |
| Continuous Operations Profit Margin | 33.14% | 34.78% | 36.03% | 31.38% | 33.92% |
| Net Income Per EBT | 78.47% | 79.40% | 79.95% | 80.40% | 80.83% |
| EBT Per EBIT | 102.26% | 99.11% | 102.05% | 92.32% | 100.74% |
| Return on Assets (ROA) | 18.87% | 21.68% | 26.61% | 23.01% | 24.55% |
| Return on Equity (ROE) | 52.79% | 70.38% | 78.53% | 66.51% | 67.50% |
| Return on Capital Employed (ROCE) | 39.01% | 51.69% | 70.82% | 62.18% | 61.74% |
| Return on Invested Capital (ROIC) | 29.53% | 38.99% | 54.20% | 49.39% | 43.62% |
| Return on Tangible Assets | 24.81% | 28.47% | 32.94% | 29.25% | 31.56% |
| Earnings Yield | 7.09% | 3.63% | 2.67% | 2.61% | 2.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.08 | 3.32 | 3.09 | 3.08 | 3.01 |
| Payables Turnover | 2.98 | 1.54 | 1.40 | 1.83 | 2.67 |
| Inventory Turnover | 1.18 | 1.09 | 1.12 | 1.17 | 1.21 |
| Fixed Asset Turnover | 1.48 | 1.79 | 2.55 | 2.65 | 2.54 |
| Asset Turnover | 0.57 | 0.62 | 0.74 | 0.73 | 0.72 |
| Working Capital Turnover Ratio | -6.19 | -6.70 | -10.86 | -13.27 | -15.32 |
| Cash Conversion Cycle | 274.83 | 208.27 | 181.60 | 231.54 | 287.19 |
| Days of Sales Outstanding | 89.41 | 109.87 | 118.27 | 118.61 | 121.32 |
| Days of Inventory Outstanding | 308.10 | 334.89 | 324.65 | 312.91 | 302.72 |
| Days of Payables Outstanding | 122.67 | 236.49 | 261.32 | 199.99 | 136.85 |
| Operating Cycle | 397.50 | 444.76 | 442.92 | 431.52 | 424.03 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 26.81 | 27.16 | 24.29 | 17.41 | 11.97 |
| Free Cash Flow Per Share | 6.52 | 15.64 | 15.62 | 14.16 | 10.36 |
| Dividend Paid and CapEx Coverage Ratio | 0.84 | 1.27 | 1.54 | 1.97 | 1.90 |
| Capital Expenditure Coverage Ratio | 1.32 | 2.36 | 2.80 | 5.35 | 7.45 |
| Operating Cash Flow Coverage Ratio | 0.91 | 1.18 | 4.03 | 3.06 | 2.06 |
| Operating Cash Flow to Sales Ratio | 0.39 | 0.42 | 0.47 | 0.45 | 0.39 |
| Free Cash Flow Yield | 2.01% | 2.51% | 2.24% | 3.02% | 2.82% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.10 | 27.53 | 37.40 | 38.27 | 35.35 |
| Price-to-Sales (P/S) Ratio | 4.68 | 9.57 | 13.47 | 12.01 | 11.99 |
| Price-to-Book (P/B) Ratio | 7.45 | 19.38 | 29.37 | 25.45 | 23.87 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 49.85 | 39.91 | 44.70 | 33.13 | 35.46 |
| Price-to-Operating Cash Flow Ratio | 12.13 | 22.98 | 28.73 | 26.94 | 30.70 |
| Price-to-Earnings Growth (PEG) Ratio | 8.20 | 1.29 | 0.72 | 2.14 | 2.33 |
| Enterprise Value Multiple | 10.37 | 20.87 | 27.41 | 27.84 | 26.06 |
| Enterprise Value | 1.55T | 2.87T | 3.14T | 2.14T | 1.70T |
| EV to EBITDA | 10.37 | 20.87 | 27.41 | 27.84 | 26.06 |
| EV to Sales | 5.01 | 9.87 | 13.53 | 12.08 | 12.10 |
| EV to Free Cash Flow | 53.45 | 41.16 | 44.88 | 33.34 | 35.79 |
| EV to Operating Cash Flow | 13.01 | 23.70 | 28.85 | 27.10 | 30.99 |
| Tangible Book Value Per Share | 14.40 | 7.27 | 10.30 | 7.08 | 6.00 |
| Shareholders’ Equity Per Share | 43.67 | 32.22 | 23.77 | 18.43 | 15.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.21 | 0.20 | 0.20 | 0.19 |
| Revenue Per Share | 69.56 | 65.20 | 51.81 | 39.06 | 30.65 |
| Net Income Per Share | 23.06 | 22.67 | 18.67 | 12.26 | 10.40 |
| Tax Burden | 0.78 | 0.79 | 0.80 | 0.80 | 0.81 |
| Interest Burden | 0.97 | 0.99 | 0.99 | 0.99 | 1.00 |
| Research & Development to Revenue | 0.17 | 0.17 | 0.14 | 0.14 | 0.13 |
| SG&A to Revenue | 0.23 | 0.23 | 0.02 | 0.03 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.16 | 1.20 | 1.30 | 1.42 | 1.15 |
Currency in DKK